How to Plan Discharge Care for Cannabis-Using Psychiatric Young Adults
How should clinicians structure discharge and early follow-up care for young adults with bipolar or psychotic disorders who report current cannabis use?
For young adults with bipolar disorder or psychotic disorders, cannabis use at admission marks a vulnerable transition period in which psychiatric readmission is most likely soon after discharge. This guide addresses what to target during hospitalization and the first month after discharge when planning care.
-
Systematically assess drug use during hospitalization
Do not rely on spontaneous disclosure alone; evaluate current cannabis use and other drug use during the inpatient stay. The article recommends that early targeted interventions focusing on drug use, particularly cannabis use, should be systematically implemented during hospitalization even in the absence of reported drug use.
-
Assess for substance use disorder when drug use is reported
If the patient reports cannabis or other drug use, evaluate for substance use disorder so that specific care measures can be implemented. This is clinically relevant because 37% of the sample had a documented substance use disorder diagnosis while only 12% were receiving specialized addiction treatment.
-
Consider toxicologic testing when mental status deteriorates
Use toxicological screening selectively in emergency or psychiatric settings when there is mental health deterioration during care. The authors specifically note this may help in the context of increasing synthetic cannabinoid exposure and high cannabis exposure in this population.
-
Deliver therapeutic education focused on cannabis and adherence
Provide education on the impact of cannabis exposure in young adults with bipolar disorder, schizophrenia, or other psychotic disorders, including the risks of poor adherence. The article recommends multidisciplinary therapeutic education to help patients understand cannabis-related risks and develop strategies to manage both treatment and cannabis use.
-
Organize multidisciplinary follow-up before discharge
Build a structured program that involves psychiatrists, addictologists, and pharmacologists, with attention to drug safety, interactions, and emerging drugs such as synthetic cannabinoids. The article recommends a structured multidisciplinary program to reduce early readmission risk in current cannabis users.
-
Strengthen social support and continuity with outpatient care
Assess the patient's environment and external social support, then coordinate follow-up with outpatient clinicians such as general practitioners and community pharmacists. This step is supported by the study's finding that absent or conflicted family relationships were independently associated with readmission and by the authors' recommendation to maintain a strong link between hospital and outpatient care.
-
Concentrate the highest follow-up intensity in the first month
Arrange the most proactive postdischarge monitoring and support during the first month after discharge, with continued attention through the first 3 months. This timing is directly supported by the study's 2.8-fold increased readmission risk during the first month and stronger association within the first 3 months.
Clinical Considerations
- The article recommends targeted and multidisciplinary interventions, but it does not test a specific discharge program or provide a validated step-by-step protocol.
- Evidence cited in the discussion suggests transitional interventions can reduce early psychiatric readmission, but post hoc assessments of psychosocial postdischarge interventions did not show positive effects on mental functioning or readmission speed.
- Digital applications and psychometric tools for cannabis use disorder are mentioned as possible options, but their effectiveness or exact implementation was not established in this study.
- Urinary toxicology was performed in only 30% of patients in the cohort, and chart-based substance documentation likely underestimated true exposure.
Bottom Line
For young adults with bipolar or psychotic disorders who use cannabis, discharge planning should explicitly target substance use and continuity of care, with the most intensive support concentrated in the first month after discharge.
